MONTREAL, Feb. 13, 2014 /CNW Telbec/ – Atrium Innovations Inc. (TSX:ATB & ATB.DB) (“Atrium” or the “Corporation“), a globally recognized leader in the development, manufacturing and
commercialization of innovative, science-based natural health products,
announced today the successful completion of the previously announced
plan of arrangement (the “Arrangement“) providing for the acquisition of all of the outstanding common shares
of Atrium (“Atrium Shares“) by corporations backed by the Permira funds (“Permira“) and the acquisition by the Corporation of all of its outstanding
5.75% convertible unsecured subordinated debentures (“Atrium Debentures“).

Pursuant to the Arrangement, the former holders of Atrium Shares (other
than the shares rolled over by Fonds de solidarit des travailleurs du Qu bec (F.T.Q.) (“Fonds“) and Caisse de d pôt et placement du Qu bec (“CDPQ“)) will receive, for each Atrium Share held, $24.00 in cash, and the
former holders of Atrium Debentures will receive, for each $1,000
principal amount of Atrium Debentures, a cash amount of approximately
$1,150 (representing the aggregate of $1,000 in principal amount,
accrued and unpaid interest on such principal amount to, but excluding,
February 13, 2014, and the interest that would otherwise be payable
thereon from and including February 13, 2014 to, but excluding, March
15, 2014, as well as the applicable “make whole premium” on the basis
of a stock price of $24.00).

Permira has delivered to Computershare Investor Services, the depositary for the Arrangement, sufficient funds
to enable the depositary to make the payments described in the
Arrangement. In accordance with the Arrangement, payment will be made
by the depositary to the holders of the Atrium Shares and Atrium
Debentures as soon as practicable following the date hereof.

It is anticipated that the Atrium Shares and the Atrium Debentures will
be delisted from the Toronto Stock Exchange on or about February 14,
2014.

About Atrium
Atrium Innovations Inc. (TSX: ATB & ATB.DB) is a globally-recognized leader in the development,
manufacturing, and commercialization of innovative, science-based
natural health products which are distributed in more than 35
countries. The Corporation owns healthcare practitioner and specialized
retail product brands that are at the forefront of science, innovation
and education. Atrium has over 1,300 employees and operates seven
manufacturing facilities with current Good Manufacturing Practices.
Additional information is available at www.atrium-innovations.com.

Cautionary Note and Forward-Looking Statements
This press release contains certain forward-looking statements with
respect to the Corporation. These forward-looking statements, by their
nature, require the Corporation to make certain assumptions and
necessarily involve known and unknown risks and uncertainties that
could cause actual results to differ materially from those expressed or
implied in these forward-looking statements. Forward-looking statements
are not guarantees of performance. These forward-looking statements,
including financial outlooks, may involve, but are not limited to,
comments with respect to the Corporation’s business or financial
objectives, its strategies or future actions, its targets, expectations
for financial condition or outlook for operations and future contingent
payments. Words such as “may”, “will”, “would”, “could”, “expect”,
“believe”, “plan”, “anticipate”, “intend”, “estimate”, “continue”, or
the negative or comparable terminology, as well as terms usually used
in the future and the conditional, are intended to identify
forward-looking statements. Information contained in forward-looking
statements is based upon certain material assumptions that were applied
in drawing a conclusion or making a forecast or projection, including
management’s perceptions of historical trends, current conditions and
expected future developments, as well as other considerations that are
believed to be appropriate in the circumstances. The Corporation
considers these assumptions to be reasonable based on information
currently available to it, but cautions the reader that these
assumptions regarding future events, many of which are beyond its
control, may ultimately prove to be incorrect since they are subject to
risks and uncertainties that affect the Corporation and its business.

For additional information with respect to these and other factors and
assumptions underlying the forward-looking statements made in this
press release, see the Corporation’s quarterly and annual Management
Discussion and Analysis for the fiscal year ended December 31, 2012 and
the management information circular dated December 17, 2013 each filed
with the Canadian securities commissions. The forward-looking
information set forth herein reflects the Corporation’s expectations as
at the date of this press release and is subject to change after such
date. The Corporation disclaims any intention or obligation to update
or revise any forward-looking statements, whether as a result of new
information, future events or otherwise, other than as required by law.

SOURCE Atrium Innovations Inc.